1 – 10 of 119
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Association Between the PRIMARY Score at Staging Prostate-specific Membrane Antigen Positron Emission Tomography and Overall Survival Among Patients with Newly Diagnosed Prostate Cancer : Findings from the International, Multicenter PROMISE Registry
- Contribution to journal › Article
-
Mark
Comparison between artificial intelligence-based and manual organ delineations in pretreatment computed tomography scans of prostate cancer patients : a visual grading study
- Contribution to journal › Article
-
Mark
Prognostic value of tumour volume based on [18F]PSMA-1007 PET/CT in prostate cancer
- Contribution to journal › Article
-
Mark
Automated RECOMIA AI-based total metabolic tumor volume in lymphoma – a retrospective study
- Contribution to journal › Article
- 2025
-
Mark
High concordance of PET-CT treatment response evaluation according to PERCIST 1.0 when comparing images reconstructed with OSEM vs. BSREM
- Contribution to journal › Article
-
Mark
Semi-standardized evaluation of extraprostatic extension and seminal vesicle invasion with [18F]PSMA-1007 PET/CT : a comparison to MRI using histopathology as reference
- Contribution to journal › Article
-
Mark
AI based automatic measurement of split renal function in [18F]PSMA-1007 PET/CT
- Contribution to journal › Article
-
Mark
Swedish national guidelines on urothelial carcinoma : 2024 update on advanced and metastatic disease
- Contribution to journal › Article
-
Mark
A fully automated AI-based method for tumour detection and quantification on [18F]PSMA-1007 PET–CT images in prostate cancer
- Contribution to journal › Article
-
Mark
Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2) : Results from an International Multicentre Registry Study
- Contribution to journal › Article
